Esperion Files For $70M IPOThe Plymouth-based cholesterol drug developer Esperion Therapeutics Inc. has filed for an initial public stock offering with the federal Securities and Exchange Commission. Esperion is seeking to raise up to $70 million.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen